NASDAQ:IMGN
ImmunoGen, Inc.
- Stock
Last Close
31.23
09/02 20:58
Market Cap
8.73B
Beta: 0.94
Volume Today
19.31M
Avg: 6.23M
PE Ratio
−109.77
PFCF: −41.03
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -71.36M - | -60.74M 14.89% | -144.82M 138.43% | -156.73M 8.23% | -96.01M 38.74% | -168.84M 75.86% | -104.13M 38.33% | -44.37M 57.39% | -222.93M 402.41% | -222.93M 0% | |
depreciation and amortization | 4.60M - | 5.51M 19.90% | 5.33M 3.37% | 6.01M 12.90% | 5.96M 0.85% | 7.41M 24.28% | 4.03M 45.65% | 2.10M 47.84% | 1.78M 15.14% | 1.78M 0% | |
deferred income tax | 18K - | 7K 61.11% | -21K 400% | -12.35M 58,704.76% | 23.15M 287.50% | 115K 99.50% | 2.38M 1,972.17% | -691K 129.00% | |||
stock based compensation | 16.08M - | 15.71M 2.27% | 22.25M 41.57% | 20.12M 9.56% | 11.32M 43.71% | 16.81M 48.41% | 14.17M 15.71% | 14.32M 1.09% | 25.61M 78.86% | 25.61M 0% | |
change in working capital | -16.58M - | -17.29M 4.25% | -2.35M 86.41% | -7.77M 230.82% | 77.58M 1,098.38% | -294K 100.38% | 25.72M 8,849.66% | -4.56M 117.71% | -25.60M 461.77% | -25.60M 0% | |
accounts receivables | -1.90M - | -3.19M 68.35% | 4.21M 231.74% | -7.12M 269.23% | -623K 91.25% | 948K 252.17% | -5.80M 711.71% | 7.46M 228.73% | -8.13M 208.89% | -8.13M 0% | |
inventory | -2.25M - | 15K 100.67% | 2.03M 13,420.00% | -655K 132.30% | 1.15M 276.18% | 1.04M 10.05% | -11.87M 1,243.83% | 10.22M 186.08% | -16.20M 258.47% | -16.20M 0% | |
accounts payables | 321K - | 3.32M 933.96% | 2.65M 20.19% | 771K - | 2.67M 245.91% | -1.04M 139.18% | -819K 21.63% | 26.73M 3,364.35% | 26.73M 0% | ||
other working capital | -12.76M - | -17.43M 36.59% | -11.23M 35.55% | 76.28M - | -4.95M 106.49% | 44.44M 998.34% | -21.42M 148.21% | -28.01M 30.75% | -28.01M 0% | ||
other non cash items | 13.60M - | 1.50M 88.98% | -4.86M 424.70% | -4.27M 12.17% | -14.37M 236.35% | -21.62M 50.45% | -30.54M 41.25% | -45.42M 48.75% | -8.67M 80.91% | -8.67M 0% | |
net cash provided by operating activities | -53.65M - | -55.29M 3.06% | -124.48M 125.13% | -142.64M 14.59% | 7.64M 105.36% | -166.42M 2,276.87% | -88.37M 46.90% | -78.62M 11.03% | -229.80M 192.29% | -229.80M 0% | |
investments in property plant and equipment | -8.18M - | -7.42M 9.27% | -10.38M 39.74% | -6.66M 35.86% | -1.12M 83.23% | -5.25M 370.07% | -2.85M 45.77% | -917K 67.77% | -1.36M 48.75% | -1.36M 0% | |
acquisitions net | 2.31M - | 1.43M 38.32% | |||||||||
purchases of investments | -1K - | ||||||||||
sales maturities of investments | |||||||||||
other investing activites | |||||||||||
net cash used for investing activites | -8.19M - | -7.42M 9.29% | -10.38M 39.74% | -6.66M 35.86% | -1.12M 83.23% | -5.25M 370.07% | -533K 89.84% | 509K 195.50% | -1.36M 367.98% | -1.36M 0% | |
debt repayment | -1.10M - | ||||||||||
common stock issued | 101.66M - | 162.51M 59.85% | 2.87M 98.23% | 194.27M 6,661.96% | 25.65M 86.80% | 25.65M 0% | |||||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 9.14M - | 198.56M 2,073.42% | 101.77M 48.75% | 96.98M 4.71% | -1.05M 101.08% | 4.30M 510.01% | 1.47M - | 3.00M 104.28% | 1.91M 36.61% | ||
net cash used provided by financing activities | 9.14M - | 198.56M 2,073.42% | 101.77M 48.75% | 96.98M 4.71% | 100.61M 3.75% | 166.81M 65.80% | 2.87M 98.28% | 195.74M 6,713.16% | 27.55M 85.92% | 27.55M 0% | |
effect of forex changes on cash | 19.24M - | ||||||||||
net change in cash | -52.70M - | 135.85M 357.78% | -33.08M 124.35% | -33.08M 0% | 107.14M 423.86% | -4.86M 104.53% | -86.03M 1,671.93% | 117.63M 236.74% | -203.61M 273.09% | -203.61M 0% | |
cash at beginning of period | 194.96M - | 142.26M 27.03% | 278.11M 95.49% | 278.11M 0% | 159.96M 42.48% | 267.11M 66.98% | 262.25M 1.82% | 176.22M 32.80% | 478.75M 171.67% | 478.75M 0% | |
cash at end of period | 142.26M - | 278.11M 95.49% | 245.03M 11.90% | 245.03M 0% | 267.11M 9.01% | 262.25M 1.82% | 176.22M 32.80% | 293.86M 66.75% | 275.14M 6.37% | 275.14M 0% | |
operating cash flow | -53.65M - | -55.29M 3.06% | -124.48M 125.13% | -142.64M 14.59% | 7.64M 105.36% | -166.42M 2,276.87% | -88.37M 46.90% | -78.62M 11.03% | -229.80M 192.29% | -229.80M 0% | |
capital expenditure | -8.18M - | -7.42M 9.27% | -10.38M 39.74% | -6.66M 35.86% | -1.12M 83.23% | -5.25M 370.07% | -2.85M 45.77% | -917K 67.77% | -1.36M 48.75% | -1.36M 0% | |
free cash flow | -61.83M - | -62.72M 1.43% | -134.85M 115.02% | -149.30M 10.71% | 6.53M 104.37% | -171.67M 2,729.32% | -91.21M 46.87% | -79.54M 12.80% | -231.17M 190.64% | -231.17M 0% |
All numbers in USD (except ratios and percentages)